Logo image of CKG.CA

CHESAPEAKE GOLD CORP (CKG.CA) Stock Fundamental Analysis

Canada - TSX-V:CKG - CA1651841027 - Common Stock

2.96 CAD
-0.18 (-5.73%)
Last: 10/9/2025, 7:00:00 PM
Fundamental Rating

3

CKG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 818 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for CKG as it has an excellent financial health rating, but there are worries on the profitability. CKG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CKG had negative earnings in the past year.
CKG had a negative operating cash flow in the past year.
In the past 5 years CKG always reported negative net income.
CKG had a negative operating cash flow in each of the past 5 years.
CKG.CA Yearly Net Income VS EBIT VS OCF VS FCFCKG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

CKG's Return On Assets of -1.51% is amongst the best of the industry. CKG outperforms 81.66% of its industry peers.
CKG has a better Return On Equity (-1.65%) than 82.89% of its industry peers.
Industry RankSector Rank
ROA -1.51%
ROE -1.65%
ROIC N/A
ROA(3y)-3.84%
ROA(5y)-3.42%
ROE(3y)-4.21%
ROE(5y)-3.74%
ROIC(3y)N/A
ROIC(5y)N/A
CKG.CA Yearly ROA, ROE, ROICCKG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2 -4 -6

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CKG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CKG.CA Yearly Profit, Operating, Gross MarginsCKG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, CKG has more shares outstanding
Compared to 5 years ago, CKG has more shares outstanding
CKG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CKG.CA Yearly Shares OutstandingCKG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CKG.CA Yearly Total Debt VS Total AssetsCKG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

CKG has an Altman-Z score of 8.58. This indicates that CKG is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 8.58, CKG is doing good in the industry, outperforming 65.53% of the companies in the same industry.
CKG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.58
ROIC/WACCN/A
WACCN/A
CKG.CA Yearly LT Debt VS Equity VS FCFCKG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

CKG has a Current Ratio of 8.24. This indicates that CKG is financially healthy and has no problem in meeting its short term obligations.
CKG's Current ratio of 8.24 is amongst the best of the industry. CKG outperforms 81.78% of its industry peers.
CKG has a Quick Ratio of 8.24. This indicates that CKG is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CKG (8.24) is better than 82.03% of its industry peers.
Industry RankSector Rank
Current Ratio 8.24
Quick Ratio 8.24
CKG.CA Yearly Current Assets VS Current LiabilitesCKG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.23% over the past year.
EPS 1Y (TTM)49.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CKG.CA Yearly EPS VS EstimatesCKG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 -0.05 -0.1 -0.15

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CKG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CKG.CA Price Earnings VS Forward Price EarningsCKG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CKG.CA Per share dataCKG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CKG!.
Industry RankSector Rank
Dividend Yield N/A

CHESAPEAKE GOLD CORP

TSX-V:CKG (10/9/2025, 7:00:00 PM)

2.96

-0.18 (-5.73%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-25 2025-08-25
Earnings (Next)11-27 2025-11-27
Inst Owners11.53%
Inst Owner ChangeN/A
Ins Owners8.05%
Ins Owner ChangeN/A
Market Cap213.39M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.42
P/tB 1.42
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS2.09
TBVpS2.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.51%
ROE -1.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.84%
ROA(5y)-3.42%
ROE(3y)-4.21%
ROE(5y)-3.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30816.7%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.24
Quick Ratio 8.24
Altman-Z 8.58
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)42551.5%
Cap/Depr(5y)32739.9%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.99%
OCF growth 3YN/A
OCF growth 5YN/A